Literature DB >> 30699312

Partial Oral Therapy for Osteomyelitis and Endocarditis - Is It Time?

Helen W Boucher1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30699312     DOI： 10.1056/NEJMe1817264

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Disparities in United States hospitalizations for serious infections in patients with and without opioid use disorder: A nationwide observational study.

Authors:  June-Ho Kim; Danielle R Fine; Lily Li; Simeon D Kimmel; Long H Ngo; Joji Suzuki; Christin N Price; Matthew V Ronan; Shoshana J Herzig
Journal:  PLoS Med       Date:  2020-08-07       Impact factor: 11.069

2.  Clinical characteristics and outcomes of patients with septic arthritis treated without surgery.

Authors:  Sarah B Lieber; Noa Alpert; Mary Louise Fowler; Robert H Shmerling; Ziv Paz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-02       Impact factor: 3.267

Review 3.  Oral or intravenous antibiotics?

Authors:  Kate McCarthy; Minyon Avent
Journal:  Aust Prescr       Date:  2020-04-01

4.  Abscess Drainage with or Without Antibiotics in Lactational Breast Abscess: Study Protocol for a Randomized Controlled Trial.

Authors:  Jiayue Luo; Tianzhu Long; Yuanxuan Cai; Yuan Teng; Zhe Fan; Zhen Liang; Cairong Zhu; Hongmin Ma; Guanhua Li
Journal:  Infect Drug Resist       Date:  2020-01-21       Impact factor: 4.003

5.  Oral Versus Standard Antimicrobial Treatment for Pyogenic Native Vertebral Osteomyelitis: A Single-Center, Retrospective, Propensity Score-Balanced Analysis.

Authors:  Lorenzo Marconi; Sara Tedeschi; Eleonora Zamparini; Silvia Terzi; Nicolò Rossi; Luca Boriani; Filippo Trapani; Maddalena Giannella; Damiano Alfio Ruinato; Elisa Marchionni; Alessandro Gasbarrini; Pierluigi Viale
Journal:  Open Forum Infect Dis       Date:  2022-07-27       Impact factor: 4.423
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.